Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
BMC Genomics ; 19(1): 548, 2018 Jul 24.
Article in English | MEDLINE | ID: mdl-30041604

ABSTRACT

BACKGROUND: The flower of the safflower (Carthamus tinctorius L.) has been widely used in traditional Chinese medicine for the ability to improve cerebral blood flow. Flavonoids are the primary bioactive components in safflower, and their biosynthesis has attracted widespread interest. Previous studies mostly used second-generation sequencing platforms to survey the putative flavonoid biosynthesis genes. For a better understanding of transcription data and the putative genes involved in flavonoid biosynthesis in safflower, we carry our study. RESULTS: High-quality RNA was extracted from six types of safflower tissue. The RNAs of different tissues were mixed equally and used for multiple size-fractionated libraries (1-2, 2-3 and 3-6 k) library construction. Five cells were carried (2 cells for 1-2 and for 2-3 k libraries and 1 cell for 3-6 k libraries). 10.43Gb clean data and 38,302 de-redundant sequences were captured. 44 unique isoforms were annotated as encoding enzymes involved in flavonoid biosynthesis. The full length flavonoid genes were characterized and their evolutional relationship and expressional pattern were analyzed. They can be divided into eight families, with a large differences in the tissue expression. The temporal expressions under MeJA treatment were also measured, 9 genes are significantly up-regulated and 2 genes are significantly down-regulated. The genes involved in flavonoid synthesis in safflower were predicted in our study. Besides, the SSR and lncRNA are also analyzed in our study. CONCLUSIONS: Full-length transcriptome sequences were used in our study. The genes involved in flavonoid synthesis in safflower were predicted in our study. Combined the determination of flavonoids, CtC4H2, CtCHS3, CtCHI3, CtF3H3, CtF3H1 are mainly participated in MeJA promoting the synthesis of flavonoids. Our results also provide a valuable resource for further study on safflower.


Subject(s)
Carthamus tinctorius/genetics , Flavonoids/biosynthesis , Transcriptome , Acetates/pharmacology , Biosynthetic Pathways/genetics , Carthamus tinctorius/drug effects , Carthamus tinctorius/metabolism , Cyclopentanes/pharmacology , Gene Expression Profiling , Gene Ontology , Genes, Plant , Microsatellite Repeats , Oxylipins/pharmacology , RNA, Long Noncoding/chemistry , Sequence Analysis, RNA
2.
J Biomol Screen ; 20(9): 1132-41, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26173710

ABSTRACT

Long non-protein coding RNAs (lncRNAs) are an important class of molecules that help orchestrate key cellular events. Although their functional roles in cells are not well understood, thousands of lncRNAs and a number of possible mechanisms by which they act have been reported. LncRNAs can exert their regulatory function in cells by interacting with epigenetic enzymes. In this study, we developed a tool to study lncRNA-protein interactions for high-throughput screening of small-molecule modulators using AlphaScreen technology. We tested the interaction of two lncRNAs: brain-derived neurotrophic factor antisense (BDNF-AS) and Hox transcript antisense RNA (HOTAIR), with Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase against a phytochemical library, to look for small-molecule inhibitors that can alter the expression of downstream target genes. We identified ellipticine, a compound that up-regulates BDNF transcription. Our study shows the feasibility of using high-throughput screening to identify modulators of lncRNA-protein interactions and paves the road for targeting lncRNAs that are dysregulated in human disorders using small-molecule therapies.


Subject(s)
High-Throughput Screening Assays , RNA, Long Noncoding/antagonists & inhibitors , Brain-Derived Neurotrophic Factor/biosynthesis , Brain-Derived Neurotrophic Factor/genetics , Drug Evaluation, Preclinical , Ellipticines/pharmacology , Enhancer of Zeste Homolog 2 Protein , Gene Expression/drug effects , HEK293 Cells , Humans , Polycomb Repressive Complex 2/biosynthesis , Polycomb Repressive Complex 2/genetics , Protein Binding/drug effects , RNA Interference/drug effects , RNA, Long Noncoding/biosynthesis , RNA, Long Noncoding/chemistry
3.
Genes Immun ; 14(7): 427-33, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23863987

ABSTRACT

Human NK cells express cell surface class I MHC receptors (killer cell immunoglobulin-like receptor, KIR) in a probabilistic manner. Previous studies have shown that a distal promoter acts in conjunction with a proximal bidirectional promoter to control the selective activation of KIR genes. We report here the presence of an intron 2 promoter in several KIR genes that produce a spliced antisense transcript. This long noncoding RNA (lncRNA) transcript contains antisense sequence complementary to KIR-coding exons 1 and 2 as well as the proximal promoter region of the KIR genes. The antisense promoter contains myeloid zinc finger 1 (MZF-1)-binding sites, a transcription factor found in hematopoietic progenitors and myeloid precursors. The KIR antisense lncRNA was detected only in progenitor cells or pluripotent cell lines, suggesting a function that is specific for stem cells. Overexpression of MZF-1 in developing NK cells led to decreased KIR expression, consistent with a role for the KIR antisense lncRNA in silencing KIR gene expression early in development.


Subject(s)
Embryonic Stem Cells/metabolism , Pluripotent Stem Cells/metabolism , RNA, Long Noncoding/genetics , Receptors, KIR/genetics , Binding Sites , Exons , Gene Silencing , HEK293 Cells , HeLa Cells , Humans , Introns , Kruppel-Like Transcription Factors/chemistry , Kruppel-Like Transcription Factors/metabolism , Promoter Regions, Genetic , RNA, Antisense/chemistry , RNA, Antisense/genetics , RNA, Antisense/metabolism , RNA, Long Noncoding/chemistry , RNA, Long Noncoding/metabolism , Receptors, KIR/metabolism
4.
Nucleic Acids Res ; 41(1): e31, 2013 Jan 07.
Article in English | MEDLINE | ID: mdl-23093590

ABSTRACT

The transcriptional silencing of one of the female X-chromosomes is a finely regulated process that requires accumulation in cis of the long non-coding RNA X-inactive-specific transcript (Xist) followed by a series of epigenetic modifications. Little is known about the molecular machinery regulating initiation and maintenance of chromosomal silencing. Here, we introduce a new version of our algorithm catRAPID to investigate Xist associations with a number of proteins involved in epigenetic regulation, nuclear scaffolding, transcription and splicing processes. Our method correctly identifies binding regions and affinities of protein interactions, providing a powerful theoretical framework for the study of X-chromosome inactivation and other events mediated by ribonucleoprotein associations.


Subject(s)
Algorithms , RNA, Long Noncoding/metabolism , RNA-Binding Proteins/metabolism , X Chromosome Inactivation , Animals , Binding Sites , Enhancer of Zeste Homolog 2 Protein , Female , Heterogeneous-Nuclear Ribonucleoprotein U/metabolism , Matrix Attachment Region Binding Proteins/metabolism , Mice , Nuclear Proteins/metabolism , Polycomb Repressive Complex 2/metabolism , RNA, Long Noncoding/chemistry , Repetitive Sequences, Nucleic Acid , Serine-Arginine Splicing Factors , YY1 Transcription Factor/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL